RDY Dr Reddys Laboratories Ltd

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

September, 2024

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                                            Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                                             No x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 

 

EXHIBITS

 

Exhibit Number		Description of Exhibits
99.1		Intimation dated September 12, 2024

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: September 12, 2024	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

 

 

 

 

Exhibit 99.1

 

Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507   Tel      : +91 40 4900 2900 Fax     : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com

 

September 12, 2024

 

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub:

Results of voting through Postal Ballot (remote e-voting) pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

 

This is in furtherance to our letter dated August 13, 2024 enclosing therein Notice of Postal Ballot seeking approval of Members of the Company for sub-division/ split of each equity share of the Company having face value of Rs. 5/- (Rupees five only) each, fully paid-up, into 5 (Five) equity shares having face value of Re. 1/- (Rupee one only) each, fully paid up, and consequent alteration of the Capital Clause of the Memorandum of Association of the Company, by way of ordinary resolution through remote e-voting.

 

We would like to inform that the ordinary resolution as set out in the said Postal Ballot Notice has been approved by the Members of the Company with requisite majority.

 

In accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summarized voting result of the remote e-voting , in the prescribed format, along with a copy of the Scrutinizer’s Report are enclosed herewith, for your information and records. The same is also being made available on the Company’s website, www.drreddys.com.

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

 

Encl: as above

 

CC: National Securities Depositary Limited (NSDL)

 

 

 

 

 

 

 

 

 

 

 

General information about company
Scrip code	500124
NSE Symbol	DRREDDY
MSEI Symbol	NOTLISTED
ISIN	INE089A01023
Name of the company	Dr. Reddy's Laboratories Limited
Type of meeting	Postal Ballot
Date of the meeting / last day of receipt of postal ballot forms (in case of Postal Ballot)	12-09-2024
Start time of the meeting
End time of the meeting

 

 

Scrutinizer Details
Name of the Scrutinizer	Alifya Sapatwala
Firms Name	Mehta & Mehta
Qualification	CS
Membership Number	24091
Date of Board Meeting in which appointed	27-07-2024
Date of Issuance of Report to the company	12-09-2024

 

Voting results
Record date	09-08-2024
Total number of shareholders on record date	284425
No. of shareholders present in the meeting either in person or through proxy
a) Promoters and Promoter group
b) Public
No. of shareholders attended the meeting through video conferencing
a) Promoters and Promoter group
b) Public
No. of resolution passed in the meeting	1

 

 

 

Resolution (1)
Resolution required: (Ordinary / Special)	Ordinary
Whether promoter/promoter group are interested in the agenda/resolution?	No
Description of resolution considered	Approval of sub-division/split of each equity share of Rs. 5/- (Rupees five only) each into 5 (five) equity shares of Re. 1/- (Rupee one only) each and consequent alteration to the Memorandum of Association of the Company

 

Category		Mode of voting		No. of shares held				No. of votes polled				% of Votes polled on outstanding shares				No. of votes – in favour				No. of votes – against				% of votes in favour on votes polled				% of Votes against on votes polled
				(1)				(2)				(3)=[(2)/(1)]*100				(4)				(5)				(6)=[(4)/(2)]*100				(7)=[(5)/(2)]*100
Promoter and Promoter Group		E-Voting							44461128				100.0000				44461128				0				100.0000				0.0000
		Poll			44461128				0				0.0000				0				0				0				0
		Postal Ballot (if applicable)							0				0.0000				0				0				0				0
		Total			44461128				44461128				100.0000				44461128				0				100.0000				0.0000
Public- Institutions		E-Voting							90885450				84.7784				90726574				158876				99.8252				0.1748
		Poll			107203568				0				0.0000				0				0				0				0
		Postal Ballot (if applicable)							0				0.0000				0				0				0				0
		Total			107203568				90885450				84.7784				90726574				158876				99.8252				0.1748
Public- Non Institutions		E-Voting							245993				1.6221				243963				2030				99.1748				0.8252
		Poll			15165005				0				0.0000				0				0				0				0
		Postal Ballot (if applicable)							0				0.0000				0				0				0				0
		Total			15165005				245993				1.6221				243963				2030				99.1748				0.8252
		Total			166829701				135592571				81.2760				135431665				160906				99.8813				0.1187
Whether resolution is Pass or Not.																									Yes

 

Details of Invalid Votes
Category		No. of Votes
Promoter and Promoter Group			0
Public Institutions			0
Public - Non Institutions			0

 

 

 

 

 

---